# Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.

> **NCT03404544** · PHASE4 · COMPLETED · sponsor: **Ciusss de L'Est de l'Île de Montréal** · enrollment: 70 (actual)

## Conditions studied

- Cesarean Section Complications
- Hemodynamic Instability

## Interventions

- **DRUG:** Carbetocin bolus
- **DRUG:** Carbetocin infusion

## Key facts

- **NCT ID:** NCT03404544
- **Lead sponsor:** Ciusss de L'Est de l'Île de Montréal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-11
- **Primary completion:** 2020-01-28
- **Final completion:** 2021-01-15
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03404544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03404544, "Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03404544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*